Open help menu
On-Demand

Latest in Evidence-Based Treatment for Opioid Use Disorder (OUD)

Benjamin Nordstrom, MD, PhD
|

Information

Recorded

  • -

Learning Objectives

Participants will be able to:

  • Discover current trends in the opioid epidemic and explain their impact on healthcare systems and patient outcomes.

  • Explain Opioid Use Disorder (OUD) as a chronic, relapsing brain disease.

  • Identify the role and effectiveness of FDA-approved medications for OUD in reducing overdose risk and supporting long-term recovery.

  • Determine specific challenges and treatment strategies for patients with fentanyl exposure.

  • Recognize common barriers that prevent individuals from accessing OUD treatment and outline practical strategies for overcoming them.

Educational Goal

Provide healthcare professionals with evidence-based best practices for treating Opioid Use Disorder (OUD), including how to select and combine FDA-approved medications with counseling and support services. Attendees will also learn how to navigate treatment barriers, address fentanyl exposure, and improve patient outcomes through effective referrals and care coordination.

Description

This webinar will equip healthcare providers and professionals who serve individuals with Opioid Use Disorder (OUD) with best practices for effective, compassionate treatment. Attendees will gain insight into how a comprehensive, evidence-based approach—combining FDA-approved medications with counseling, case management, peer support and wraparound services—improves outcomes and saves lives. The session will also highlight strategies for improving care coordination and building stronger referral pathways.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Psychologist
  • Social Worker

Presenters

Benjamin Nordstrom, MD, PhD
Dr. Nordstrom is a Board-Certified Addiction Psychiatrist. Prior to coming to BHG, he was on the faculty of the medical schools of Dartmouth College and the University of Pennsylvania, where he led addiction treatment services and taught at the undergraduate, graduate, and postgraduate level.  Dr. Nordstrom was previously the Chief Clinical Officer and later the CEO of Phoenix House, a national provider of addiction treatment services. He served on the ASAM committee that generated National Practice Guidelines for the use of medications in the treatment of opioid use disorder and was a co-leader of the quality improvement learning collaboratives as part of the state of Vermont’s Hub and Spoke initiative. In addition, Dr. Nordstrom has deployed twice as a psychiatrist with the Army Reserves.  He received his medical degree from Dartmouth, his PhD in Criminology from the University of Pennsylvania, and completed his psychiatry and addiction psychiatry training at Columbia University Medical Center and the New York State Psychiatric Institute.

Financially Sponsored By

  • Behavioral Health Group (BHG)